Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 24-26,1986
First Statement of Responsibility
edited by Fritz Melchers, Michael Potter.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Berlin, Heidelberg
Name of Publisher, Distributor, etc.
Springer Berlin Heidelberg
Date of Publication, Distribution, etc.
1986
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xii, 374 pages 156 illustrations)
SERIES
Series Title
Current topics in microbiology and immunology, 132.
CONTENTS NOTE
Text of Note
B-cell Tumors in Transgenic Mice Carrying c-mycSequences --;c-Myc-Induced Lymphomagenesis in Transgenic Mice and the Role of the Pvt-1 Locus in Lymphoid Neoplasia. --;Lymphohematopoietic and Other Malignant Neoplasms Occurring Spontaneously in Transgenic Mice Carrying and Expressing MTV/myc Fusion Genes --;Induction of B-cell Tumors with Retroviral Constructs Containing Oncogenes --;Tumors of Newborn NFS/N Mice Infected with Murine Retroviruses Containing Avian v-Myc --;Induction of Clonal Monocyte/Macrophage Tumors invivo by a Mouse c-myc Retroviruses: Evidence for Secondary Transforming Events --;Induction of Hematopoietic Tumors Using a Viral Construct Containing c-myc cDNA from Normal Mouse Spleen --;Rapid Induction of Plasmacytomas in Mice by Pristane and a Murine Recombinant Retrovirus Containing an Avian v-myc and a Defective raf Oncogene --;Transformation and Insertional Mutagenesis in Vitro of Primary Hematopoietic Stem Cell Cultures --;Induction of B-cell and Other Tumors in Vitro --;Mammalian Cell Transformation by a Recombinant Murine Retrovirus Containing the Avian Erythroblastosis Virus erbB Gene --;Determinants of Abelson Murine Leukemia Virus Pathogenesis --;An In Vitro Model for Tumor Progression in Murine Lymphoid Cells --;Structural Modification of c-abl in Lymphoma and Leukemia --;Transposable Elements and Cancer --;B-Lymphocyte/Plasma Cell Growth Factors, Receptors --;Alpha-type B Cell Growth Factor and Complement Component C3: Their Possible Structural Relationship --;A Growth-Factor Dependent B-Cell Hybridoma --;A Growth Factor Required by Plasmacytoma Cells In Vitro --;Genes Affecting the Production or Action of B Cell-Active Lymphokines --;Lymphokine Regulation of Murine IgE Production --;Interleukin-4 (B Cell Growth Factor-II/Eosinophil Differentiation Factor) is a Mitogen and Differentiation Factor for Preactivated Murine B Lymphocytes --;Role of the LFA-1 Molecule in B Cell Differentiation --;Studies on Transferrin Receptor Expression in Mouse Plasmacytoma Cells --;Structure and Expression of c-myb Protooncogene mRNA in Murine B-Cells --;Chromosome Translocations, Breaks --;Genomic Activity and Translocation in Lymphocytes --;Possible Role of Immunoglobulin Recombination Sequences in the Genesis of Variant t (2;8) Translocations of Burkitt Lymphoma --;C-Myc Activation in Spontaneous Rat Immunocytomas Containing a 6;7 Chromosomal Translocation --;The Molecular Genetics of Human T Cell Leukemias and Lymphomas --;Molecular Genetics of Human B-cell Neoplasia --;C-myc and Functionally Related Oncogenes Induce Both High Rates of Sister Chromatid Exchange and Abnormal Karyotypes in Rat Fibroblasts --;Chromosomal Radiosensitivity During G2 Phase and Susceptibility to Plasmacytoma Induction in Mice --;Biology of B Cell Tumor Development --;Normal and Neoplastic B Cell Development in the Bursa of Fabricius --;Restrictions That Influence Avian Leukosis Virus-Induced Lymphoid Leukosis --;Benign Monoclonal Gammapathy (BMG) --;DNA Rearrangement and Expression of the c-myc Gene in a Human Myeloma --;Inbred Strain Differences Influence the Focal Proliferation of Plasma Cells in Pristane Induced Oil Granuloma --;Molecular Analysis of myc Gene Mutants --;EBV-Virus, Burkitt's Lymphoma --;Induction of fgr Proto-oncogene mRNA in B Lymphocytes as a Consequence of Epstein- Barr Virus Infection --;Epstein-Barr Virus Induced Differentiation of Early B-Lineage Cells --;Epstein-Barr Virus Gene Expression During Primary B-Lymphocyte Infection, in Transformed and Burkitt Lymphoma-Derived Cell Lines --;Structure and Expression of Translocated c-myc Oncogenes: Specific Differences in Endemic, Sporadic and AIDS-Associated Forms of Burkitt Lymphomas --;EBV-Activation of Human B-Lymphocytes --;Regulation of c-myc Expression --;Myc Expression in vivo During Human Embryogenesis --;Expression of c-myc and c-fos During Phorbol Ester Induced Differentiation of B-type Chronic Lymphocytic Leukemia Cells --;Regulation of c-myc mRNA and Protein Levels During Activation of Normal Human B Cells --;Differential Expression of N-myc, c-myc and c-src Proto-oncogenes During the Course of Induced Differentiation of Murine Embryonal Carcinoma Cells --;Complex Regulation of c-myc Gene Expression in a Murine B Cell Lymphoma --;Activation of Proto-oncogene Expression by Growth Regulatory Signals --;Biological Effects of High Level c-myc Expression in FR3T3 Fibroblasts --;A Transfected c-myc Oncogene Inhibits Mouse Erythroleukemic Differentiation --;Myc Transcription, Post Transcription --;Altered c-myc RNA Metabolism in Burkitt's Lymphomas and Mouse Plasmacytomas --;Mutations Which Stabilize myc Transcripts and Enhance myc Transcription in Two Mouse Plasmacytomas --;Studies on c-myc Regulation in Normal and Transformed Cells --;Myc Gene Product --;Characterization and Nuclear Localization of the v- and c-myc Proteins --;Characterisation of Human myc Proteins --;Indexed in Current Contents.